75 related articles for article (PubMed ID: 8077801)
1. Blood lipid changes in hypertensive, dyslipidemic patients under long term quinapril treatment.
Cangelosi MM; Gaudio M; Brancati AM; Leggio F
Int Angiol; 1994 Mar; 13(1):65-7. PubMed ID: 8077801
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients.
Kanbay M; Yildirir A; Bozbas H; Ulus T; Bilgi M; Muderrisoglu H; Akcay A; Ozdemir FN
Ren Fail; 2005; 27(3):297-303. PubMed ID: 15957546
[TBL] [Abstract][Full Text] [Related]
4. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
5. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
Larochelle P; Haynes B; Maron N; Dugas S
Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
[TBL] [Abstract][Full Text] [Related]
6. [Indapamide--a substitute diuretic for hypertensives with hyperglycemia and/or dyslipidemia].
Sharabi Y; Grossman E; Nussinovitch N; Katz A; Rachima-Moaz C; Rosenthal T
Harefuah; 1996 Oct; 131(7-8):233-6, 295. PubMed ID: 8940516
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
8. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
Sánchez S; Luna A; Orozco R; Velasco G
Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
[TBL] [Abstract][Full Text] [Related]
10. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
11. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
Almenar L; Osa A; Palencia M; Flores A; Sánchez E
J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
May HT; Anderson JL; Pearson RR; Jensen JR; Horne BD; Lavasani F; Yannicelli HD; Muhlestein JB
Am J Cardiol; 2008 Feb; 101(4):486-9. PubMed ID: 18312763
[TBL] [Abstract][Full Text] [Related]
13. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
McKenney JM
Pharmacotherapy; 1993; 13(4):340-52. PubMed ID: 8361860
[TBL] [Abstract][Full Text] [Related]
14. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents.
Canter DA; Texter MJ; McLain RW
J Hypertens Suppl; 1994; 12(7):S33-8. PubMed ID: 7769502
[TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
Udawat H; Goyal RK
Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
[TBL] [Abstract][Full Text] [Related]
17. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive drugs and blood lipids: the Oslo study.
Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
[TBL] [Abstract][Full Text] [Related]
19. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.
Nguyen NT; Varela E; Sabio A; Tran CL; Stamos M; Wilson SE
J Am Coll Surg; 2006 Jul; 203(1):24-9. PubMed ID: 16798484
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
